Literature DB >> 20789250

Chronic Bronchitis and the General Practitioner.

.   

Abstract

Entities:  

Year:  1961        PMID: 20789250      PMCID: PMC1970179     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  13 in total

1.  Prophylactic chemotherapy in chronic bronchitis.

Authors:  E N MOYES; S Z KALINOWSKI
Journal:  Tubercle       Date:  1959-04

2.  Absorption and utility of lobeline as a smoking deterrent.

Authors:  G W RAPP; B T DUSZA; L BLANCHET
Journal:  Am J Med Sci       Date:  1959-03       Impact factor: 2.378

3.  Tobacco smoking, respiratory symptoms, and ventilatory capacity; studies in random samples of the population.

Authors:  I T HIGGINS
Journal:  Br Med J       Date:  1959-02-07

4.  Long-term prophylactic administration of tetracycline to chronic bronchitics.

Authors:  J BUCHANAN; W W BUCHANAN; A G MELROSE; J B McGUINNESS; A U PRICE
Journal:  Lancet       Date:  1958-10-04       Impact factor: 79.321

5.  Respiratory symptoms, bronchitis, and ventilatory capacity in men. An Anglo-Danish comparison, with special reference to differences in smoking habits.

Authors:  H C OLSEN; J C GILSON
Journal:  Br Med J       Date:  1960-02-13

6.  Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis.

Authors:  P C ELMES; C M FLETCHER; A A DUTTON
Journal:  Br Med J       Date:  1957-11-30

7.  Adult chronic bronchitis; the infective factor and its treatment.

Authors:  G EDWARDS; A R BUCKLEY; E C FEAR; G M WILLIAMSON; K ZINNEMANN
Journal:  Br Med J       Date:  1957-08-03

8.  The effectiveness of meprobamate and lobeline as smoking deterrents.

Authors:  W A BARTLETT; R W WHITEHEAD
Journal:  J Lab Clin Med       Date:  1957-08

9.  Long-continued treatment with tetracycline and prednisolone in chronic bronchitis; a controlled trial.

Authors:  E N MOYES; R A KERSHAW
Journal:  Lancet       Date:  1957-12-14       Impact factor: 79.321

10.  Long-term oxytetracycline (terramycin) therapy in advanced chronic respiratory infections.

Authors:  W H HELM; J R MAY; J L LIVINGSTONE
Journal:  Lancet       Date:  1956-05-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.